SHIFT-Hospital@Home pilot study

The current problem is that there can be a discontinuity in medical care when transferring from hospital to the home environment, particularly at weekends and on public holidays. This is often a critical phase in the treatment process.

In the SHIFT-B3 "Hospital@Home" pilot study, innovative telemedical treatment processes are being demonstrated to counteract this problem. The primary research questions being investigated are the health status of patients and the satisfaction of patients and doctors involved (Study NCT05617560, Clinicaltrials.gov). The study procedure is as follows:

The people identified by the University Hospital Basel (USB) for treatment will be offered participation in the pilot study in consultation with their GPs after receiving detailed information. If they agree to participate in the study, relevant information will be transmitted from the USB to Medgate. Medgate's telemedicine-trained doctors will contact the participants no later than the day after they leave hospital and look after them during the critical phase after hospital discharge. They enquire about the patient's state of health, resolve any uncertainties, record vital signs, adjust treatment if necessary or refer the patient back to hospital if the condition deteriorates. Participants have the opportunity to contact Medgate at any time during the telemedical care if their health deteriorates or if they have important questions about their state of health. At the end of the telemedical care, the participants are returned to the care of their general practitioners, who are informed in writing about the progress of the telemedical treatment.